Skip to main content
RKLBFYI

Intelligence Hub

Market analytics and operational performance indicators

Last Updated: 18 minutes ago
Back to Filings
FORM 4
AI

Insider Trading - August 29, 2025

Filed August 29, 2025
·
Period ending August 27, 2025
·
0002001011-25-000065

Director Possenriede acquired 3,960 RSUs ($0) via compensation grant.

Brief

Kenneth R. Possenriede, Director at Rocket Lab USA (RKLB), acquired 3,960 restricted stock units (RSUs) on 08/27/2025 at $0.00 per share. This standard compensation grant increases his direct holdings to 94,178 shares. Neutral signal as routine director equity award.

Detailed Brief

Kenneth R. Possenriede, a Director of Rocket Lab USA Inc. (NASDAQ: RKLB), received a grant of 3,960 RSUs on August 27, 2025, under the Rocket Lab Corporation Amended and Restated Non-Employee Director Compensation Policy and the 2021 Stock Option and Incentive Plan. The RSUs were acquired at $0.00 per share (transaction code A) with no cash consideration, vesting in full on the earlier of the next Annual Meeting of Stockholders or the one-year anniversary of the grant date, subject to continuous board service. Following the transaction, he owns 94,178 shares directly. The Form 4 was filed on August 29, 2025, with no 10b5-1 plan indicated or prior trading pattern referenced in the filing. This is a standard quarterly or annual director compensation practice, carrying no unusual bullish or bearish implications.

Key Telemetry

  • Routine grant of 3,960 RSUs (~4% increase to 94,178 direct shares)
  • Standard non-employee director compensation; vests in ~1 year
  • Neutral price context ($0 grant); no market purchase
  • Timing pre-next earnings cycle; no announcements tied

Impact Vector

This routine RSU grant reflects standard director compensation practices and ongoing board commitment but signals neutral insider confidence, lacking discretionary purchase intent.

Search
Search across missions, customers, news, and SEC filings